Fund Holdings — Aisling Capital Management LP

Total Portfolio Value
$456.45M
Total Bought
$69.68M
Total Sold
$1.04M
Net Transaction
+$68.64M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma Inc. (BBIO)(BBIO)6,068,1256,089,611+21,486262,022316,29469.29%+54,273
Syndax Pharmaceuticals, Inc. (SNDX)(SNDX)1,316,8061,316,806012,32520,2664.44%+7,940
Verona Pharma plc (VRNA)615,352615,352058,20065,66414.39%+7,464
BridgeBio Oncology Therapeutics (BBOT)(BBOT)0564,625+564,62506,5381.43%+6,538
Nuvation Bio Inc. (NUVB)(NUVB)2,541,0092,960,659+419,6504,95510,9542.40%+5,999
Monte Rosa Therapeutics Inc (GLUE)(GLUE)1,472,3311,472,33106,64010,9102.39%+4,270
Bicara Therapeutics Inc. (BCAX)568,919568,91905,2858,9831.97%+3,698
Compass Pathways Plc (CMPS)(CMPS)1,198,4181,198,41803,3566,8671.50%+3,511
Scholar Rock Holding Corporation (SRRK)(SRRK)077,031+77,03102,8690.63%+2,869
CalciMedica, Inc. (CALC)(CALC)521,114521,11408341,6030.35%+769
Biomea Fusion Inc (BMEA)(BMEA)2,048,7572,048,75703,6884,1380.91%+451
Aclaris Therapeutics Inc (ACRS)(ACRS)434,455434,45506178250.18%+209
OnKure Therapeutics, Inc. (OKUR)(OKUR)88,60788,60702122440.05%+32
Marker Therapeutics, Inc. (MRKR)(MRKR)325,370325,37004982900.06%-207
Elevation Oncology Inc (ELEV)2,834,9100-2,834,9101,0410—-1,041
Page 1 of 1
Aisling Capital Management LP — 13F Holdings — Q3 2025 | TickerTrail